Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 35% ± 13% | |
| basal cell | 4 studies | 24% ± 5% | |
| epithelial cell | 3 studies | 20% ± 4% | |
| retinal rod cell | 3 studies | 23% ± 5% | |
| retinal pigment epithelial cell | 3 studies | 38% ± 13% | |
| type I pneumocyte | 3 studies | 24% ± 6% | |
| Schwann cell | 3 studies | 23% ± 6% | |
| melanocyte | 3 studies | 45% ± 21% |
Insufficient scRNA-seq data for expression of ST6GALNAC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 93% | 268.61 | 427 / 459 | 83% | 13.72 | 926 / 1118 |
| thymus | 100% | 429.04 | 650 / 653 | 68% | 5.96 | 413 / 605 |
| esophagus | 98% | 318.99 | 1422 / 1445 | 66% | 12.26 | 121 / 183 |
| skin | 72% | 549.30 | 1304 / 1809 | 92% | 35.87 | 433 / 472 |
| lung | 94% | 308.65 | 546 / 578 | 62% | 9.96 | 720 / 1155 |
| bladder | 86% | 296.81 | 18 / 21 | 45% | 5.02 | 228 / 504 |
| prostate | 97% | 318.91 | 238 / 245 | 16% | 0.71 | 78 / 502 |
| kidney | 89% | 175.78 | 79 / 89 | 22% | 1.69 | 197 / 901 |
| uterus | 41% | 81.81 | 70 / 170 | 69% | 9.38 | 315 / 459 |
| pancreas | 75% | 105.75 | 246 / 328 | 31% | 1.77 | 55 / 178 |
| stomach | 84% | 145.97 | 301 / 359 | 21% | 1.33 | 60 / 286 |
| intestine | 83% | 289.66 | 802 / 966 | 18% | 1.09 | 96 / 527 |
| eye | 0% | 0 | 0 / 0 | 100% | 79.73 | 80 / 80 |
| ovary | 11% | 14.64 | 20 / 180 | 89% | 17.83 | 382 / 430 |
| muscle | 98% | 328.13 | 785 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 16.73 | 43 / 45 |
| adipose | 79% | 139.89 | 948 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 69% | 376.08 | 645 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 55% | 79.31 | 141 / 258 | 5% | 0.31 | 11 / 230 |
| heart | 54% | 69.35 | 462 / 861 | 0% | 0 | 0 / 0 |
| spleen | 50% | 59.93 | 121 / 241 | 0% | 0 | 0 / 0 |
| brain | 10% | 16.24 | 261 / 2642 | 5% | 0.30 | 34 / 705 |
| blood vessel | 14% | 30.13 | 184 / 1335 | 0% | 0 | 0 / 0 |
| liver | 1% | 1.04 | 3 / 226 | 7% | 0.38 | 29 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1990743 | Biological process | protein sialylation |
| GO_0016266 | Biological process | O-glycan processing |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0019082 | Biological process | viral protein processing |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0001665 | Molecular function | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
| GO_0008373 | Molecular function | sialyltransferase activity |
| Gene name | ST6GALNAC2 |
| Protein name | Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase (EC 2.4.3.3) ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
| Synonyms | SIATL1 SIAT7B STHM |
| Description | FUNCTION: Catalyzes the transfer of N-acetylneuraminyl groups onto glycan chains in glycoproteins . Shows a preference for N-acetylgalactosamine (GalNAc) residues already modified by the addition of galactose or galactose followed by sialic acid in alpha-2,3 linkage . . |
| Accessions | K7EMI2 K7EMM1 ENST00000585736.1 K7EKT8 ENST00000585390.1 ENST00000225276.10 ENST00000588920.1 Q9UJ37 K7EIW2 ENST00000588120.5 |
